Skip to main content
EJNMMI Research

Table 2 Median (IQR) SUV70 measurements

From: Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy

All patients (n = 102)

 

Benign (n = 87)

Malignant (n = 15)

P1

P2

P3

SUV1

1.8 (1.5–2.2; 0.6)

2.6 (1.9–4.7; 2.8)

0.001

  

SUV2

1.7 (1.4–2.2; 0.8)

2.7 (1.6–5.9; 4.3)

0.001

0.28

0.04

RI

− 2.6 (− 16.7–4.5; 21.2)

12.3 (− 11.6–25.6; 37.2)

0.018

  

Visually equivocal patient group (n = 24)

 

Benign (n = 18)

Malignant (n = 6)

P1

P2

P3

SUV1

2.3 (2.1–2.4; 0.3)

2.6 (2.3–3.2; 0.9)

0.04

  

SUV2

2.2 (2.0–2.7; 0.7)

2.6 (2.5–3.7; 1.2)

0.03

0.65

0.08

RI

− 0.6 (− 3.8–8.9; 12.6)

9.9 (1.2–15.9; 14.8)

0.18

  
  1. Bold was used to indicate statistical significant P values
  2. P1 Mann–Whitney U test comparing SUV values of malignant and benign nodes. P2 and P3 Wilcoxon signed ranks test comparing SUV2 versus SUV1 of benign (P2) and malignant (P3) nodes
Back to article page